Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice

by Elena Iemma | Jun 16, 2022

Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice

A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform

by Elena Iemma | Jun 7, 2022

A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation

by Elena Iemma | Sep 10, 2021

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation

by Elena Iemma | May 13, 2021

Identification of a Tolerogenic Factor V Peptide and its Potential Role in Factor VIII Tolerance Induction

by Annie De Groot | Oct 8, 2018

EpiVax_ECI2018_poster_Identification of a Tolerogenic Factor V Peptide_30Aug2018